SCHEMBL8793829

SCHEMBL8793829

O=C1N=NC(=O)c2c1[nH]c1cc(Br)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 9/20 0.48
GSK3A P49840 6/20 0.48
CDK5 Q00535 5/20 0.48
CDK5R1 Q15078 5/20 0.48
CCNB2 O95067 4/20 0.48
CDK1 P06493 4/20 0.48
CCNB1 P14635 4/20 0.48
CCNB3 Q8WWL7 4/20 0.48
CDK4 P11802 3/20 0.44
CCND1 P24385 3/20 0.44
CAMK2B Q13554 2/20 0.44
CAMK2G Q13555 2/20 0.44
CAMK2D Q13557 2/20 0.44
CAMK2A Q9UQM7 2/20 0.44
CCNT1 O60563 1/20 0.44
CCNE2 O96020 1/20 0.44
EIF2AK2 P19525 1/20 0.44
CCNA2 P20248 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8794489 0.80 PARP1 (0.49) GSK3BGSK3ACDK5CDK5R1CCNB2
SCHEMBL8795167 0.80 GSK3B (0.44) GSK3BGSK3ACDK5CDK5R1CCNB2
SCHEMBL7412080 0.77 ALDH1A1 (0.48) GSK3BGSK3ACDK5CDK5R1CCNB2
SCHEMBL8794843 0.76 KDM4E (0.53) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL8793865 0.76 KIF11 (0.51) CDK4CCND1MAPTNFKB1
SCHEMBL8794545 0.73 GPR17 (0.35) GSK3BGSK3ACDK5CDK5R1CCNB2
SCHEMBL8796099 0.71 GRIN2D (0.50) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL17867262 0.70 GSK3B (0.46) GSK3BGSK3ACDK5CDK5R1CCNB2
SCHEMBL8794931 0.70 KDM4E (0.48) GSK3BGSK3ACAMK2BCAMK2GCAMK2D
SCHEMBL181890 0.69 METAP2 (0.52) GSK3BGSK3ACDK5CDK5R1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0512817-B1 Pyridazinedione derivatives, their preparation and pharmaceutical applications ZENECA LTD (GB) 1997-02-19 EP claimed
EP-0512817-A1 Pyridazinedione derivatives, their preparation and pharmaceutical applications ZENECA LIMITED (GB) 1992-11-11 EP claimed
US-5652239-A TREATMENT OF STROKES, ISCHEMIC ATTACK, ANTAGONISTS OF EXCITATORY AMINO ACIDS GLUTAMATE AND ASPARTATE IMPERIAL CHEMICAL COMPANY (GB) 1997-07-29 US disclosed
EP-0512817-B1 Pyridazinedione derivatives, their preparation and pharmaceutical applications ZENECA LTD (GB) 1997-02-19 EP disclosed
EP-0671378-B1 Process for the preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl-methylketone, its derivatives and stereoisomers BASF AG (DE) 1997-01-29 EP disclosed
EP-0671378-A1 Process for the preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl-methylketone, its derivatives and stereoisomers BASF AKTIENGESELLSCHAFT (DE) 1995-09-13 EP disclosed
EP-0512817-A1 Pyridazinedione derivatives, their preparation and pharmaceutical applications ZENECA LIMITED (GB) 1992-11-11 EP disclosed